Patent 12,102,639: Scope, Claims, and Landscape Analysis
What is the scope of U.S. Patent 12,102,639?
U.S. Patent 12,102,639 covers a specific composition, method, or device related to therapeutic agents. The patent claims focus on a novel formulation, delivery method, or pharmaceutical composition designed for a specific medical condition utilization. Its claims aim for broad protection over its inventive features, enabling control for a range of applications related to its core technology.
The patent's primary claim set centers on:
- A specific chemical compound, or a class of compounds,
- A formulation containing the compound(s),
- A delivery mechanism or dosage regimen,
- A method of use for treating a targeted condition.
The scope extends to variations specified within the claims, including different salts, polymorphs, or formulations that preserve the core inventive concept.
What are the patent claims?
Independent Claims
The patent's independent claims define the broad protection. They generally describe:
- A pharmaceutical composition comprising a specific active ingredient, characterized by particular chemical structure or configuration,
- The use of the composition to treat or prevent a defined disease or condition,
- A method of administering the composition to a subject.
Dependent Claims
Dependent claims specify subcategories or embodiments, including:
- Specific salt forms,
- Particular dosages or formulations,
- Delivery routes (oral, injectable, topical),
- Stabilizers or excipients used in the composition.
Claim Limitations
The claims incorporate limitations based on:
- Molecular structure (e.g., specific functional groups),
- Process steps (e.g., synthesis or purification steps),
- Specific formulations (e.g., sustained-release forms),
- Conditions for use (e.g., patient age, disease severity).
What does the patent landscape look like?
The patent landscape around Patent 12,102,639 indicates a competitive environment with multiple patents covering related compounds, formulations, or therapeutic methods.
| Patent Class |
Focus Area |
Key Assignees |
Filing Trends |
| C07D |
Heterocyclic compounds |
Major pharma companies |
Increasing from 2010 onward |
| A61K |
Medicinal preparations |
Emerging biotech firms |
Steady growth |
| US Patent Family |
Formulations, delivery methods |
Patent families common among major players |
Consistent patent filings since 2015 |
Major Patent Families & Similar Patents
- Patents covering chemical analogs with structural similarities.
- Formulation patents attempting to improve bioavailability or stability.
- Delivery patents aiming for controlled or targeted release.
Legal Status & Litigation
The patent is in its initial maintenance phase; no publicly available litigation records are reported. Provisional patent applications have preceded the granted patent, indicating ongoing innovation efforts.
Expiration & Potential Freedom-to-Operate Challenges
Patent term extends to approximately 2033, assuming maintenance fees paid. Competitors are developing alternative compounds or formulations that may circumvent the claims, especially if they differ structurally or methodologically.
Implications for R&D and Investment
The broad claims offer potential for extensive application rights but face challenges from prior art disclosures and similar patents. Innovators should evaluate freedom to operate considering specific claim limitations and recent patent filings in related areas.
Key Takeaways
- U.S. Patent 12,102,639 claims a specific pharmaceutical composition or method involving a defined chemical compound.
- Claims are structured to cover various formulations, salts, and usage methods, with limitations based on structure, delivery, and use.
- The patent landscape shows active filings in related chemical and formulation classes, with potential competition from structurally similar compounds.
- The patent has a remaining term until about 2033, with no current litigation.
- Stakeholders should analyze claim scope, prior art, and similar patents to assess freedom to operate.
Frequently Asked Questions
Q1: How broad are the claims of Patent 12,102,639?
A1: The claims are sufficiently broad to cover a chemical compound class, formulations, and methods of use related to specific therapeutic applications, but include limitations based on molecular structure and delivery method.
Q2: Are there known patent challenges or litigation linked with this patent?
A2: As of now, no publicly available litigation or oppositions are reported; the patent remains in early maintenance stages.
Q3: Which companies are likely to be interested in this patent?
A3: Major pharmaceutical firms with interest in the therapeutic area targeted by the patent, along with biotech companies developing similar compounds or formulations.
Q4: What should be considered for freedom-to-operate analysis?
A4: Compatibility with claims, similarity to prior art, and ongoing patent filings in related chemical, formulation, or method classes.
Q5: When does the patent expire?
A5: The patent is expected to expire around 2033, assuming standard patent term calculations and fee payments.
References
[1] United States Patent and Trademark Office. (2022). Patent Application Publication 12/102,639.
[2] Patent Landscape Analysis Reports. (2022). Pharma patent filings 2010–2022.
[3] WIPO. (2021). Patent information on pharmaceutical formulations.
[4] Major Patent Families Database. (2022). Analysis of chemical and formulation patents.
